October 15, 2018
Companies join forces to target different T cell subsets and combat cancer CAMBRIDGE, Mass., PARIS and SHANGHAI – Oct. 15, 2018 – HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, announced today the acquisition of H-Immune Therapeutics, an early-stage biotechnology company engaged in the discovery and development...
Read More